FeNO Non-Suppression Identifies Corticosteroid-Resistant Type-2 Signaling in Severe Asthma. Couillard S, Shrimanker R, Chaudhuri R, Mansur AH, et al. Am J Respir Crit Care Med 2021 Jun 15. doi: 10.1164/rccm.202104-1040.

Read + Share

Amedeo Smart

Independent Medical Education

Couillard S, Shrimanker R, Chaudhuri R, Mansur AH, et al. FeNO Non-Suppression Identifies Corticosteroid-Resistant Type-2 Signaling in Severe Asthma. Am J Respir Crit Care Med 2021 Jun 15. doi: 10.1164/rccm.202104-1040.
PMID: 34129808